Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples

Transportation Research Board 88th Annual MeetingTransportation Research Board(2020)10.3389/fcimb.2020.00444Source: DataRank Database

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples is a research paper published in Transportation Research Board 88th Annual MeetingTransportation Research Board (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: goldTopics (27)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Annalis Whitaker,Jan Wilhelm,Jimena Ovalle,Ruth Pérez ORCID,Francisca Valdivieso

Live enrichment

PubMed:33042854 PMC:PMC7527604

NIAID NIH HHS

Grant: T32 AI055402

NIAID NIH HHS

Grant: U19 AI045452

NIAID NIH HHS

Grant: R41 AI132047

NIAID NIH HHS

Grant: R43 AI142911

National Institutes of Health

Grant: 3U19AI045452-05S1

HANTAVIRUS ECOLOGY AND DISEASE IN CHILE

National Institutes of Health

Grant: 1R41AI132047-01

Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndrome

National Institutes of Health

Grant: 1R43AI142911-01

A novel antibody therapy for Sin Nombre virus infection

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Institutes of Health

Fondo Nacional de Desarrollo Científico y Tecnológico

Consejo Nacional de Innovación, Ciencia y Tecnología

University of Vermont

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fcimb.2020.00444/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fcimb.2020.00444/full

repositoryhttps://doaj.org/article/0c1ea6365436490dab9b319daf13683f

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7527604

Europe_PMChttps://europepmc.org/articles/PMC7527604

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansHantavirus InfectionsAntibodies, ViralNeutralization TestsAntibodies, NeutralizingOrthohantavirus

Keywords

Neutralizing AntibodiesHantavirus Cardiopulmonary Syndrome (Hcps)OrthohantavirusAndes Orthohantavirus (Andv)Vesicular Stomatitis Virus (Vsv) PseudovirusHantavirus Infections610Antibodies, ViralMicrobiologyAntibodies, NeutralizingQR1-502Cellular and Infection MicrobiologyNeutralization Tests03 Salud y bienestar616Andes orthohantavirus(ANDV)Humans03 Good Health and Well-being

Sustainable Development Goals

SDG 3: 3. Good health